Why GE HealthCare Technologies (GEHC) Stock Is Down Today

GE HealthCare Technologies (GEHC) is down 5.9% today. Here is some analysis on what might have caused this price movement.

Analysis: There does not appear to be a fresh company-specific negative announcement on July 14, so the selloff looks more likely tied to lingering concerns about margins and trade-related input costs ahead of the company’s July 29 earnings report. This could also be because investors are still weighing the weaker profit outlook GE HealthCare gave in late April and the view that macro pressures may continue to cap near-term upside. ([investor.gehealthcare.com](https://investor.gehealthcare.com/news-events/news-releases))

Details:

GE HealthCare’s investor relations page shows its most recent releases were a July 8 research collaboration update and the scheduling of second-quarter 2026 results for July 29, rather than a new negative development today. ([investor.gehealthcare.com](https://investor.gehealthcare.com/news-events/news-releases))

In first-quarter 2026 results released on April 29, the company said profitability was hurt by a supplier issue that has since been resolved, along with higher memory chip, oil, and freight costs. ([gehealthcare.com](https://www.gehealthcare.com/en-us/about/newsroom/press-releases/ge-healthCare-reports-first-quarter-2026-financial-results))

That same earnings update said GE HealthCare reduced its profit outlook while keeping topline growth guidance, signaling that margins, not demand alone, were the bigger concern. ([gehealthcare.com](https://www.gehealthcare.com/en-us/about/newsroom/press-releases/ge-healthCare-reports-first-quarter-2026-financial-results))

An April 30 analyst downgrade highlighted rising input costs, tariff fluctuations, and reduced earnings expectations, which may still be acting as an overhang on the shares. ([investing.com](https://www.investing.com/news/analyst-ratings/goldman-sachs-cuts-ge-healthcare-stock-rating-on-rising-input-costs-93CH-4647652))

Sources:

GE HealthCare, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$GEHC Insider Trading Activity

$GEHC insiders have traded $GEHC stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $GEHC stock by insiders over the last 6 months:

H LAWRENCE JR CULP purchased 80,805 shares for an estimated $5,000,076
KEVIN LOBO purchased 10,000 shares for an estimated $641,800
PETER J ARDUINI (President and CEO) purchased 4,169 shares for an estimated $249,827
JAMES SACCARO (Chief Financial Officer) purchased 3,310 shares for an estimated $200,585
FRANK R JIMENEZ (GC & Corporate Secretary) purchased 1,750 shares for an estimated $105,787
RODNEY F HOCHMAN purchased 1,618 shares for an estimated $100,364

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive GEHC Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$GEHC Hedge Fund Activity

We have seen 458 institutional investors add shares of $GEHC stock to their portfolio, and 585 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

AUTO-OWNERS INSURANCE CO removed 33,568,289 shares (-98.8%) from their portfolio in Q1 2026, for an estimated $2,335,010,182
BARROW HANLEY MEWHINNEY & STRAUSS LLC added 5,378,190 shares (+82.7%) to their portfolio in Q1 2026, for an estimated $374,106,896
CYNOSURE GROUP, LLC removed 4,344,817 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $302,225,470
CAPITAL RESEARCH GLOBAL INVESTORS removed 4,253,599 shares (-16.8%) from their portfolio in Q1 2026, for an estimated $295,880,346
HOLOCENE ADVISORS, LP removed 2,246,830 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $156,289,494
MIZUHO MARKETS AMERICAS LLC removed 1,945,500 shares (-99.3%) from their portfolio in Q1 2026, for an estimated $135,328,980
MIZUHO MARKETS CAYMAN LP added 1,945,500 shares (+173.2%) to their portfolio in Q1 2026, for an estimated $135,328,980

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$GEHC Congressional Stock Trading

Members of Congress have traded $GEHC stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $GEHC stock by members of Congress over the last 6 months:

REPRESENTATIVE TERRI A. SEWELL sold up to $15,000 on 03/25.
REPRESENTATIVE WARREN DAVIDSON sold up to $15,000 on 03/23.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$GEHC Analyst Ratings

Wall Street analysts have issued reports on $GEHC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Evercore ISI Group issued a "Outperform" rating on 04/30/2026
BTIG issued a "Buy" rating on 04/29/2026
Piper Sandler issued a "Overweight" rating on 01/30/2026

To track analyst ratings and price targets for $GEHC, check out Quiver Quantitative's $GEHC forecast page.

$GEHC Price Targets

Multiple analysts have issued price targets for $GEHC recently. We have seen 14 analysts offer price targets for $GEHC in the last 6 months, with a median target of $79.0.

Here are some recent targets:

An analyst from BMO Capital set a target price of $70.0 on 07/09/2026
Shagun Singh from RBC Capital set a target price of $80.0 on 06/23/2026
Graham Doyle from UBS set a target price of $69.0 on 05/21/2026
Larry Biegelsen from Wells Fargo set a target price of $75.0 on 04/30/2026
Matt Miksic from Barclays set a target price of $78.0 on 04/30/2026
Vijay Kumar from Evercore ISI Group set a target price of $80.0 on 04/30/2026
David Roman from Goldman Sachs set a target price of $65.0 on 04/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.